VKTX
Viking Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -25.0% ·
share flow -10.9% ·
net new positions -20.0%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 29.61K | $851,871 | n/a | n/a |
| Q2 2026 | 109 | +6 | 57.62M | $2.25B | +10 | −4 |
| Q1 2026 | 106 | -1 | 56.45M | $1.88B | +7 | −8 |
| Q4 2025 | 106 | +1 | 58.95M | $2.07B | +2 | −1 |
| Q3 2025 | 16 | -1 | 41.62M | $1.09B | +2 | −4 |
| Q2 2025 | 15 | 0 | 36.99M | $980.19M | +2 | −2 |
| Q1 2025 | 12 | +3 | 10.64M | $256.98M | +3 | n/a |
| Q4 2024 | 9 | -3 | 10.39M | $418.15M | n/a | −3 |
| Q3 2024 | 11 | -1 | 6.74M | $426.33M | n/a | −1 |
| Q2 2024 | 12 | n/a | 5.57M | $295.04M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 4.93M | n/a | $198.20M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.88M | +0.9% | $75.70M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Citadel Advisors ✦ | 1.49M | +0.8% | $59.76M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (passive) | 1.28M | +0.7% | $51.46M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 537.24K | +15.9% | $21.52M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 6 | Millennium Management ✦ | 102.73K | -40.4% | $4.13M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 102.24K | -77.6% | $4.11M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 8 | T. Rowe Price ✦ | 60.72K | -3.1% | $2.44M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Marshall Wace ✦ | 20.11K | +12.6% | $809,387 | 0.0% | ▲ Add | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Viking Global Investors | $45.71M | was 0.2% |
| Renaissance Technologies | $11.66M | was 0.0% |
| Two Sigma Investments | $3.26M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 9.80K shares, $318 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.